Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease скачать в хорошем качестве

Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease

👁️ Advancements in nAMD and DMO care with Prof. Peter Kaiser Retinal diseases like neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) are leading causes of vision loss globally. Treatments for these conditions can impose a significant burden on patients and caregivers. In this touchEXPERT FOCUS, Prof. Peter Kaiser discusses the latest advancements in treating nAMD and DMO. He explores how treatments with longer dosing intervals are transforming the treatment landscape and helping to ease the burden on patients, and caregivers. Key Insights: The evolving treatment landscape for nAMD and DMO How extended dosing intervals reduce the treatment burden for patients and caregivers Practical tips for integrating these treatments into clinical practice Stay ahead in retinal disease care. 👉 Watch the full interview and learn how to apply these advancements to your practice: https://touchophthalmologyime.org/ado... This activity is funded by an independent medical education grant from Bayer Consumer Care AG. The activity is provided by touchIME. touchIME is an EBAC® accredited provider. #RetinalHealth #nAMD #DMO #ExtendedDosing #PatientCare #HealthcareInnovation #Ophthalmology #ClinicalPractice